221 related articles for article (PubMed ID: 30305705)
1. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.
Skandali N; Rowe JB; Voon V; Deakin JB; Cardinal RN; Cormack F; Passamonti L; Bevan-Jones WR; Regenthal R; Chamberlain SR; Robbins TW; Sahakian BJ
Neuropsychopharmacology; 2018 Dec; 43(13):2645-2651. PubMed ID: 30305705
[TBL] [Abstract][Full Text] [Related]
2. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
3. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study.
Langley C; Armand S; Luo Q; Savulich G; Segerberg T; Søndergaard A; Pedersen EB; Svart N; Overgaard-Hansen O; Johansen A; Borgsted C; Cardinal RN; Robbins TW; Stenbæk DS; Knudsen GM; Sahakian BJ
Neuropsychopharmacology; 2023 Mar; 48(4):664-670. PubMed ID: 36683090
[TBL] [Abstract][Full Text] [Related]
4. The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls.
Lochner C; Chamberlain SR; Kidd M; Taljaard L; Fineberg NA; Robbins TW; Stein DJ
Psychopharmacology (Berl); 2020 Oct; 237(10):3117-3123. PubMed ID: 32638035
[TBL] [Abstract][Full Text] [Related]
5. The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning.
Brown HD; Amodeo DA; Sweeney JA; Ragozzino ME
J Psychopharmacol; 2012 Nov; 26(11):1443-55. PubMed ID: 22219222
[TBL] [Abstract][Full Text] [Related]
6. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder.
Lochner C; Simmons C; Kidd M; Chamberlain SR; Fineberg NA; van Honk J; Ipser J; Stein DJ
Behav Brain Res; 2012 Jan; 226(1):274-80. PubMed ID: 21963422
[TBL] [Abstract][Full Text] [Related]
8. Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval.
Reed MB; Vanicek T; Seiger R; Klöbl M; Spurny B; Handschuh P; Ritter V; Unterholzner J; Godbersen GM; Gryglewski G; Kraus C; Winkler D; Hahn A; Lanzenberger R
Neuroimage; 2021 Aug; 236():118039. PubMed ID: 33852940
[TBL] [Abstract][Full Text] [Related]
9. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
[TBL] [Abstract][Full Text] [Related]
10. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Wingen M; Kuypers KP; Ramaekers JG
J Psychopharmacol; 2007 Jul; 21(5):477-85. PubMed ID: 17092965
[TBL] [Abstract][Full Text] [Related]
11. 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.
Furr A; Lapiz-Bluhm MD; Morilak DA
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1295-305. PubMed ID: 22008191
[TBL] [Abstract][Full Text] [Related]
12. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
13. Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women.
Outhred T; Das P; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
J Psychiatry Neurosci; 2014 Jul; 39(4):267-75. PubMed ID: 24690370
[TBL] [Abstract][Full Text] [Related]
14. Establishing a probabilistic reversal learning test in mice: evidence for the processes mediating reward-stay and punishment-shift behaviour and for their modulation by serotonin.
Ineichen C; Sigrist H; Spinelli S; Lesch KP; Sautter E; Seifritz E; Pryce CR
Neuropharmacology; 2012 Nov; 63(6):1012-21. PubMed ID: 22824190
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.
Drueke B; Baetz J; Boecker M; Moeller O; Hiemke C; Gründer G; Gauggel S
Psychopharmacology (Berl); 2009 Dec; 207(2):213-23. PubMed ID: 19756527
[TBL] [Abstract][Full Text] [Related]
17. Effect of escitalopram on the processing of emotional faces.
Alves-Neto WC; Guapo VG; Graeff FG; Deakin JF; Del-Ben CM
Braz J Med Biol Res; 2010 Mar; 43(3):285-9. PubMed ID: 20209375
[TBL] [Abstract][Full Text] [Related]
18. Conditional inactivation of Npy1r gene in mice induces behavioural inflexibility and orbitofrontal cortex hyperactivity that are reversed by escitalopram.
Longo A; Fadda M; Brasso C; Mele P; Palanza P; Nanavaty I; Bertocchi I; Oberto A; Eva C
Neuropharmacology; 2018 May; 133():12-22. PubMed ID: 29353053
[TBL] [Abstract][Full Text] [Related]
19. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram effects on insula and amygdala BOLD activation during emotional processing.
Arce E; Simmons AN; Lovero KL; Stein MB; Paulus MP
Psychopharmacology (Berl); 2008 Mar; 196(4):661-72. PubMed ID: 18058090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
